RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1%
July 30, 2019 07:21 ET
|
RECORDATI
RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA(1) +7.4%, NET INCOME +6.1% ·Consolidated revenues € 743.3 million, +6.8%.·EBITDA (1) € 279.3 million, +7.4%·Operating income...
RECORDATI: ACCORDO PER L’ACQUISIZIONE DEI DIRITTI PER SIGNIFOR® E OSILODROSTAT (LCI699) A LIVELLO MONDIALE
July 12, 2019 14:30 ET
|
RECORDATI
RECORDATI: ACCORDO PER L’ACQUISIZIONE DEI DIRITTI PER SIGNIFOR® E OSILODROSTAT (LCI699) A LIVELLO MONDIALE Milano, 12 luglio 2019– Recordati annuncia la firma di un accordo con Novartis per...
RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699)
July 12, 2019 14:30 ET
|
RECORDATI
RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699) Milan, 12 July 2019 – Recordati announces the signing of an agreement with Novartis for the acquisition of worldwide...
RECORDATI RARE DISEASES, PRIMARIA SOCIETÀ A LIVELLO MONDIALE NEL TRATTAMENTO DI MALATTIE RARE E FARMACI ORFANI
June 24, 2019 02:35 ET
|
RECORDATI
RECORDATI RARE DISEASES, PRIMARIA SOCIETÀ A LIVELLO MONDIALE NEL TRATTAMENTO DI MALATTIE RARE E FARMACI ORFANI Milano, 24 giugno 2019 – Recordati Rare Diseases, leader a livello mondiale nel...
RECORDATI RARE DISEASES, A WORLDWIDE LEADER IN RARE DISEASES AND ORPHAN DRUGS
June 24, 2019 02:35 ET
|
RECORDATI
RECORDATI RARE DISEASES, A WORLDWIDE LEADER IN RARE DISEASES AND ORPHAN DRUGS Milan, 24 June 2019 – Recordati Rare Diseases, a worldwide leader in rare diseases and orphan drugs, today reported that...
RECORDATI: RISULTATI IN CRESCITA NEL PRIMO TRIMESTRE 2019. APPROVATO NUOVO PIANO INDUSTRIALE TRIENNALE
May 08, 2019 06:27 ET
|
RECORDATI
RECORDATI: RISULTATI IN CRESCITA NEL PRIMO TRIMESTRE 2019. APPROVATO NUOVO PIANO INDUSTRIALE TRIENNALE. Ricavi netti consolidati € 383,0 milioni, +4,5%.EBITDA (1) € 143,9 milioni, +7,1%.Utile...
RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2019. NEW THREE YEAR BUSINESS PLAN APPROVED
May 08, 2019 06:27 ET
|
RECORDATI
RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2019. NEW THREE YEAR BUSINESS PLAN APPROVED. Consolidated revenues € 383.0 million, +4.5%.EBITDA (1) € 143.9 million, +7.1%Operating income € 126.0...
RECORDATI INCONTRA LA COMUNITÀ FINANZIARIA
April 15, 2019 03:10 ET
|
RECORDATI
RECORDATI INCONTRA LA COMUNITÀ FINANZIARIA Milano, 15 aprile 2019 - Recordati S.p.A. incontrerà la comunità finanziaria: Giovedì, 9 maggio p.v., alle ore 10:30 GMT (Registrazione ore...
RECORDATI TO MEET WITH THE FINANCIAL COMMUNITY
April 15, 2019 03:10 ET
|
RECORDATI
RECORDATI TO MEET WITH THE FINANCIAL COMMUNITY Milan, 15 April 2019 – Recordati S.p.A. will be hosting a meeting with the financial community on: Thursday 9 May at 10:30 am GMT (Registration at 9:30...
RECORDATI SHAREHOLDERS APPROVE THE 2018 ACCOUNTS. DIVIDEND € 0.92 PER SHARE (+8.2% vs 2017)
April 11, 2019 08:41 ET
|
RECORDATI
RECORDATI SHAREHOLDERS APPROVE THE 2018 ACCOUNTS. DIVIDEND € 0.92 PER SHARE (+8.2% vs 2017). Shareholders approve the 2018 results: consolidated revenues € 1,352.2 million (+5.0% vs 2017), operating...